


ENYO Pharma Revenue
Biotechnology Research • Lyon, Auvergne-Rhône-Alpes, France • 21-50 Employees
ENYO Pharma revenue & valuation
| Annual revenue | $19,000,000 |
| Revenue per employee | $514,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $60,800,000 |
| Total funding | No funding |
Key Contact at ENYO Pharma
Sarah Smith
Business Director
Company overview
| Headquarters | 60 avenue Rockefeller, 69008 LYON, France, Bioserra 1, Bâtiment B, Lyon, Rhône-Alpes 69008, FR |
| Phone number | +33437700219 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Founded | 2014 |
| Employees | 21-50 |
| Socials |
ENYO Pharma Email Formats
ENYO Pharma uses 1 email format. The most common is {2char} (e.g., {2char}@enyopharma.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{2char} | {2char}@enyopharma.com | 100% |
About ENYO Pharma
ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
ENYO Pharma has 13 employees across 7 departments.
Departments
Number of employees
Funding Data
ENYO Pharma has never raised funding before.
ENYO Pharma Tech Stack
Discover the technologies and tools that power ENYO Pharma's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript frameworks
JavaScript libraries
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
Programming languages
Security
WordPress plugins
Blogs
Frequently asked questions
4.8
40,000 users



